Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00503347
Recruitment Status : Completed
First Posted : July 18, 2007
Last Update Posted : June 9, 2011
Information provided by:
Peregrine Pharmaceuticals

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2011
  Study Completion Date : June 2011